Catalyst Wire Dossier Catalyst Wire Dossier

UNITUXIN

dinutuximab · United Therapeutics Corporation
Drug timelines are a Plus or Pro feature.

11 regulatory and trial events tracked for UNITUXIN, covering 2015-03-10 to 2026-04-13. Get the full timeline:

Most recent: Clinical Trial Update: Lenalidomide and Dinutuximab With or Without Isotretinoin in Treating Younger Patients With Refractory or Recurrent Neuroblastoma [Phase 1]

See pricing